Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
Clinical trial NCT00483366 · COMPLETED
Trial details
- NCT number
- NCT00483366
- Sponsor
- University of Nebraska
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-15
- Primary completion
- 2009-01-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.